These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 5712917)

  • 1. [Conn's syndrome and similar diseases].
    Fukuchi S; Katsushima I
    Saishin Igaku; 1968 Dec; 23(12):2521-6. PubMed ID: 5712917
    [No Abstract]   [Full Text] [Related]  

  • 2. Arterial blood pressure and plasma and body electrolytes in idiopathic hyperaldosteronism: a comparison with primary hyperaldosteronism (Conn's syndrome) and essential hypertension.
    Lasaridis A; Brown JJ; Davies DL; Fraser R; Robertson JI; Lever AF
    J Hypertens; 1984 Aug; 2(4):329-36. PubMed ID: 6530544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body elemental composition, with particular reference to total and exchangeable sodium and potassium and total chlorine, in untreated and treated primary hyperaldosteronism.
    Williams ED; Boddy K; Brown JJ; Cumming AM; Davies DL; Harvey IR; Haywood JK; Lever AF; Robertson JI
    J Hypertens; 1984 Apr; 2(2):171-6. PubMed ID: 6533185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biochemical detection of Conn's adenoma: definition of criteria and reference values].
    Gosse P; Guiheneuf-Tobie C; Lasserre R; Minifie C; Lemetayer P; Clementy J
    Arch Mal Coeur Vaiss; 2005 Mar; 98(3):181-5. PubMed ID: 15816319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone secretion and sodium balance in salt-losing nephropathy.
    Walker WG; Jost LJ; Kowarski A; Dunn MJ
    Johns Hopkins Med J; 1968 Jan; 122(1):45-54. PubMed ID: 5638341
    [No Abstract]   [Full Text] [Related]  

  • 6. Modification of the effects of aldosterone on electrolyte excretion in man by simultaneous administration of corticosterone and hydrocortisone. Relevance to Conn's syndrome.
    ROSS EJ
    J Clin Endocrinol Metab; 1960 Feb; 20():229-37. PubMed ID: 13854575
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation of plasma renin activity and aldosterone secretion rate in hypertensive patients.
    Schönbeck M; Siegenthaler W; Weidmann P; Endres P; Baumann K; Gysling E; Werning C
    Helv Med Acta; 1969 Jan; 34(5):386-400. PubMed ID: 5766169
    [No Abstract]   [Full Text] [Related]  

  • 8. Conn's syndrome: a simple diagnostic approach.
    Mathew S; Perakath B; Nair A; Rajaratnam S; Seshadri MS
    Natl Med J India; 1999; 12(5):214-6. PubMed ID: 10613001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The significance of sodium intake in postoperative aldosteronism].
    Schildberg FW; Witte J; Bachhuber F; Schreiber M
    Chir Forum Exp Klin Forsch; 1977 Apr; ():41-4. PubMed ID: 618311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudohyperaldosteronism with renal tubular resistance to mineralocorticoid hormones.
    Rodriguez JA; Biglieri EG; Schambelan M
    Trans Assoc Am Physicians; 1981; 94():172-82. PubMed ID: 7046191
    [No Abstract]   [Full Text] [Related]  

  • 11. Atrial fibrillation associated with hypokalemia due to primary hyperaldosteronism (Conn's syndrome).
    Al-Aloul B; Li JM; Benditt D; Tholakanahalli V
    Pacing Clin Electrophysiol; 2006 Nov; 29(11):1303-5. PubMed ID: 17100688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Crohn's disease and Conn's syndrome. A report of two cases.
    Astegiano M; Bresso F; Demarchi B; Sapone N; Novero D; Palestro G; Resegotti A; Pellicano R; Rizzetto M
    Panminerva Med; 2005 Mar; 47(1):61-4. PubMed ID: 15985978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary aldosteronism, a common entity? the myth persists.
    Padfield PL
    J Hum Hypertens; 2002 Mar; 16(3):159-62. PubMed ID: 11896504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypokalemic paralysis due to primary hyperaldosteronism simulating Gitelman's syndrome.
    Kasifoglu T; Akalin A; Cansu DU; Korkmaz C
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):285-7. PubMed ID: 19237821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemistry of saliva in primary hyperaldosteronism (Conn's syndrome)].
    Kreusser W; Heidland A; Hennemann A; Wigand ME
    Arch Klin Exp Ohren Nasen Kehlkopfheilkd; 1972; 202(2):430-4. PubMed ID: 4646110
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnosis and management of Conn's syndrome].
    Vallotton MB
    Rev Med Suisse Romande; 1999 Jun; 119(6):445-8. PubMed ID: 10422466
    [No Abstract]   [Full Text] [Related]  

  • 17. Latent tetany associated with the hypokalaemia of Conn's syndrome.
    Davies JS; Aguirre G; Cassidy DM; Griffiths BE
    Int J Clin Pract; 1998; 52(5):347-8. PubMed ID: 9796569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The plasma renin activity in arterial hypertension with adrenocortical adenoma (Conn's syndrome)].
    Meyer P; Ménard J; Alexandre JM; Devaux C; Druet P; Milliez P
    Presse Med (1893); 1966 Jun; 74(30):1585-90. PubMed ID: 5932440
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I.
    Stowasser M; Bachmann AW; Jonsson JR; Tunny TJ; Klemm SA; Gordon RD
    J Hypertens; 1995 Dec; 13(12 Pt 2):1610-3. PubMed ID: 8903619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone and other mineralocorticoids in Bartter's syndrome.
    Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
    J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.